Showing the single result
Deferasirox Tablets
FreeProduct Composition & Strength
We supply this product across two distinct, Precision-Blended Engineering Platforms, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical and chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength & Form Primary Clinical Function Deferasirox USP/Ph.Eur. 125 mg / 250 mg / 500 mg (Dispersible) The Pediatric Suspension Standard: Engineered with micro-crystalline disintegrants to rapidly dissolve in water or apple juice for precise, weight-based pediatric dosing. Deferasirox USP/Ph.Eur. 90 mg / 360 mg (Film-Coated) The High-Compliance Macrodose: The highly densified, lactose-free therapeutic payload designed to be swallowed whole, minimizing GI distress for adult patients. (Note: 360mg FCT is clinically equivalent to 500mg DT). Excipients (FCT Matrix) Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Poloxamer 188 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Solubilizer / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced High-Shear Wet Granulation and Poloxamer Solubilization. Because the FCT tablet is highly densified, it requires elite surfactants to guarantee instantaneous release and absorption in the gastrointestinal tract without the need for pre-dispersion) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for strict, 30-day chronic hematology dispensing regimens).
